Treatment And Prevention Data Of Chlamydia - Essay Example

Challenges in Finding Chlamydia Treatment and Prevention Data Challenges in Finding Chlamydia Treatment and Prevention Data Introduction The collection of accurate counts of screened cases of chlamydia has proven to be difficult to health plans. The use of Logical Observation Identifiers Names and Codes has been popular among providers. Its use provides an electronic system for recording screening and treatment tests. Plan-selected laboratories are also usable by health plans, which imply that those conducting the research obtain the records of screening and treatment from selected laboratories.

The following section contains some of the challenges faced in collection of the treatment and prevention data, other development issues and concerns about chlamydia. While offering treatment for the disease and contribution techniques for prevention, some communities were against open discussions on sexually transmitted diseases and sexual practices. Particular people believed that openly talking about the topic would instead of help in prevention, indulge in more sexual activities. Therefore, a majority of the communities resisted attempts of open discussion.

Additionally, the collection of data from physicians was compromised by fact that most of them never carried out treatment for chlamydia patients unless they were willing to pay. As a result of this, providers were unable to have the correct representation of patient data. Furthermore, data collected from some laboratory tests were incomplete because some technicians failed to update regularly patient data. Incomplete information was a major challenge in data collection process even among the patients because of the stigma associated with chlamydia.

Most patients faced hardships in expressing their conditions to physicians; hence, inhibiting the correct collection of data. Moreover, patient confidentiality issue arose since the providers who delivered the information felt they had the obligation to maintain their patients’ secrets. Other challenges that the group encountered comprised of inadequate team members to collect data from the wide range of providers. Since the group only comprised of a few participants, there was a workload in the collection of data concerning the treatment and prevention of the illness.

The individuals could not produce a representative number of the wider patient size. Additionally, the timing was not enough for the full assessment of activities meant to prevent the condition. Partner institutions in the prevention of Sexually Transmitted Diseases include the National Chlamydia Coalition and the Division of Sexually Transmitted Disease Prevention. Assessing all these organizations needed a longer period than just one and half a month. Concerns about chlamydia are on the stigma and intolerance of some communities to take preventive advice.

The assertion of Douglas, Berman and Walsh (2008) is that patients of chlamydia experience much stigma in seeking treatment of the illness. According to the data collected, it was evident that very few patients sort medical attention since others feel embarrassed and ashamed of their conditions. Some fear to compromise the confidentiality of their illness, eventually reach parents, friends and spouses, leading to stigma (Douglas, Berman, and Walsh 2008). Additionally, the research revealed that some communities resisted health plan efforts to discuss openly sexual matters, especially to the youths.

As per the customs of some communities, engaging in such talks only increases the engagement rather than withdrawal of their youngsters from engaging in sexual activities. Intolerance from the community and the stigma associated with chlamydia, therefore, are great concerns that hinder proper treatment and prevention of the disease. Intensifying Sexually Transmitted Disease Risk Reduction, Counselling Services should be strengthened to cover for proper counselling for partners. Furthermore, they should ensure provision of prevention counselling to help reduce the spread.

Reference Douglas, J. M., Berman, S. S., & Walsh, C. (2008). A word about chlamydia screening in managed care organizations in the prevention of sexually transmitted diseases. NCQA. Retrieved December 6, 2015, from https://www.ncqa.org/Portals/0/Publications/Resource%20Library/Improving_Chlamydia_Screening_08.pdf